| | | | Presenting companies are hand-selected for the event, and consist of a selection of recent IPOs to established large-cap public companies. Presenters at the BIO CEO & Investor Conference attract and successfully schedule 40% more BIO One-on-One Partnering™ meetings than non-presenting companies!
Tell your story to public and private equity investors, as well as industry analysts, investment bankers, and senior biotechnology executives. Investor registration is up 35% over last year's record-breaking participation! Already, AbbVie Ventures, Bank of America, Merrill Lynch, Carlyle Group, GE Ventures, Guggenheim Partners, Jefferies, Mizuho Corporate Bank, Morgan Stanley, NEA, SVB, and many more have registered to attend.
| |
| |
|
|
| | | | Just Announced: Fireside Chat Speakers:
Deborah Dunsire, MD | President and Chief Executive Officer, XTuit Pharmaceuticals Lan Huang, PhD | Co-Founder, Charmain and Chief Executive Officer, BeyondSpring Pharmaceuticals Jeffrey D. Marrazzo | Co-Founder and Chief Executive Officer, Spark Therapeutics Vivek Ramaswamy | Founder and Chief Executive Officer, Roivant Sciences Vicki Sato, PhD | Chairman, Denali Therapeutics; Chairman, Vir Biotechnology To view the preliminary program, please click here. | |
| |
|
|
| | | | Reserve Your Housing Book your room at the NY Marriott Marquis for $199/night by January 26, 2018 to take advantage of this special rate. | |
| |
|
|
